Asymptomatic carriers for homozygous novel mutations in the FKRP gene: the other end of the spectrum.

Eur J Hum Genet

1Centro de Estudos do Genoma Humano, Instituto de Biociências, Universidade de São Paulo, São Paulo, Brazil.

Published: December 2003

Autosomal recessive limb-girdle muscular dystrophy linked to 19q13.3 (LGMD2I) was recently related to mutations in the fukutin-related protein gene (FKRP) gene. Pathogenic changes in the same gene were detected in congenital muscular dystrophy patients (MDC1C), a severe disorder. We have screened 86 LGMD genealogies to assess the frequency and distribution of mutations in the FKRP gene in Brazilian LGMD patients. We found 13 Brazilian genealogies, including 20 individuals with mutations in the FKRP gene, and identified nine novel pathogenic changes. The commonest C826A European mutation was found in 30% (9/26) of the mutated LGMD2I alleles. One affected patient homozygous for the FKRP (C826A) mutation also carries a missense R125H change in one allele of the caveolin-3 gene (responsible for LGMD1C muscular dystrophy). Two of her normal sibs were found to be double heterozygotes. In two unrelated LGMD2I families, homozygous for novel missense mutations, we identified four asymptomatic carriers, all older than 20 years. Genotype-phenotype correlation studies in the present study as well as in patients from different populations suggests that the spectrum of variability associated with mutations in the FKRP gene seems to be wider than in other forms of LGMD. It also reinforces the observations that pathogenic mutations are not always determinant of an abnormal phenotype, suggesting the possibility of other mechanisms modulating the severity of the phenotype that opens new avenues for therapeutic approaches.

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.ejhg.5201066DOI Listing

Publication Analysis

Top Keywords

fkrp gene
20
mutations fkrp
16
muscular dystrophy
12
asymptomatic carriers
8
homozygous novel
8
gene
8
pathogenic changes
8
mutations
7
fkrp
6
carriers homozygous
4

Similar Publications

Ribitol and ribose treatments differentially affect metabolism of muscle tissue in FKRP mutant mice.

Sci Rep

January 2025

McColl-Lockwood Laboratory for Muscular Dystrophy Research, Carolinas Medical Center, Atrium Health Musculoskeletal Institute, 1000 Blythe Blvd. , Charlotte, NC, 28231, USA.

Dystroglycanopathy is characterized by reduced or lack of matriglycan, a cellular receptor for laminin as well as other extracellular matrix proteins. Recent studies have delineated the glycan chain structure of the matriglycan and the pathway with key components identified. FKRP functions as ribitol-5-phosphate transferase with CDP-ribitol as the substrate for the extension of the glycan chain.

View Article and Find Full Text PDF

Objective: Limb-girdle muscular dystrophy R9 (LGMDR9, formerly known as LGMD2I), caused by variants in the fukutin-related protein (FKRP) gene leads to progressive muscle weakness of the shoulder and pelvic limb-girdles and loss of motor function over time. Clinical management and future trial design are improved by determining which standardized clinical outcome assessments (COA) of function are most appropriate to capture disease presentation and progression, informing endpoint selection and enrollment criteria. The purpose of our study was to evaluate the cross-sectional validity and reliability of clinical outcome assessments in patients with FKRP-related LGMDR9 participating in the Genetic Resolution and Assessments Solving Phenotypes in LGMD (GRASP) natural history study.

View Article and Find Full Text PDF
Article Synopsis
  • Pathogenic variants in the FKRP gene cause various muscular dystrophies, including Limb-Girdle Muscular Dystrophy type 9 (LGMDR9), which is notably prevalent in Italy.
  • A study analyzed 153 patients from Southern Italy showing Duchenne/Becker-like symptoms, identifying pathogenic variants in 16 individuals, with specific variants frequently found.
  • The findings emphasize the need to include LGMDR9 in the diagnosis of dystrophinopathies, aiming to improve the identification and management of affected patients in Calabria.
View Article and Find Full Text PDF

Interpretation of disease-causing genetic variants remains a challenge in human genetics. Current costs and complexity of deep mutational scanning methods are obstacles for achieving genome-wide resolution of variants in disease-related genes. Our framework, saturation mutagenesis-reinforced functional assays (SMuRF), offers simple and cost-effective saturation mutagenesis paired with streamlined functional assays to enhance the interpretation of unresolved variants.

View Article and Find Full Text PDF

Clinical and genetic evaluation of hereditary myopathies in an adult Saudi cohort.

BMC Neurol

September 2024

Department of Internal Medicine, College of Medicine, King Saud University, PO Box 7805, Riyadh, 11472, Saudi Arabia.

Article Synopsis
  • * Out of 87 patients, limb-girdle muscular dystrophy (LGMD) was the most common diagnosis, with 68% of tested patients achieving a genetic diagnosis, primarily identifying dysferlinopathy and FKRP-related disorders.
  • * The study emphasizes the importance of various molecular genetic testing methods, particularly noting their success rates, and advocates for better access to advanced testing for conditions like FSHD and mitochondrial myopathies.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!